乐胖代购免代理版

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:07:18Z","timestamp":1715983638460},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T00:00:00Z","timestamp":1212537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s11517-008-0354-7","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T11:59:23Z","timestamp":1212494363000},"page":"1039-1049","source":"Crossref","is-referenced-by-count":22,"title":["Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants"],"prefix":"10.1007","volume":"46","author":[{"given":"Brent D.","family":"Weinberg","sequence":"first","affiliation":[]},{"given":"Ravi B.","family":"Patel","sequence":"additional","affiliation":[]},{"given":"Hanping","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Elvin","family":"Blanco","sequence":"additional","affiliation":[]},{"given":"Carlton C.","family":"Barnett","sequence":"additional","affiliation":[]},{"given":"Agata A.","family":"Exner","sequence":"additional","affiliation":[]},{"given":"Gerald M.","family":"Saidel","sequence":"additional","affiliation":[]},{"given":"Jinming","family":"Gao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,6,4]]},"reference":[{"key":"354_CR1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/sonc.2001.26951","volume":"28","author":"CC Barnett Jr","year":"2001","unstructured":"Barnett CC Jr, Curley SA (2001) Ablative techniques for hepatocellular carcinoma. Semin Oncol 28:487\u2013496","journal-title":"Semin Oncol"},{"key":"354_CR2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00464-006-9139-y","volume":"21","author":"E Berber","year":"2007","unstructured":"Berber E, Siperstein AE (2007) Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases. Surg Endosc 21:613\u2013618","journal-title":"Surg Endosc"},{"key":"354_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01896905","volume":"26","author":"C Bertazzoli","year":"1970","unstructured":"Bertazzoli C, Chieli T, Grandi M et al (1970) Adriamycin: toxicity data. Experientia 26:389\u2013390","journal-title":"Experientia"},{"key":"354_CR4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.sla.0000118373.31781.f2","volume":"239","author":"SA Curley","year":"2004","unstructured":"Curley SA, Marra P, Beaty K et al (2004) Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239:450\u2013458","journal-title":"Ann Surg"},{"key":"354_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1016083113123","volume":"13","author":"LK Fung","year":"1996","unstructured":"Fung LK, Shin M, Tyler B et al (1996) Chemotherapeutic drugs released from polymers: distribution of 1, 3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm Res 13:671\u2013682","journal-title":"Pharm Res"},{"key":"354_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semradonc.2005.04.004","volume":"15","author":"CJ Gannon","year":"2005","unstructured":"Gannon CJ, Curley SA (2005) The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol 15:265\u2013272","journal-title":"Semin Radiat Oncol"},{"key":"354_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0929-8266(01)00126-4","volume":"13","author":"SN Goldberg","year":"2001","unstructured":"Goldberg SN (2001) Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 13:129\u2013147","journal-title":"Eur J Ultrasound"},{"key":"354_CR8","first-page":"S37","volume":"6","author":"P Grimm","year":"2004","unstructured":"Grimm P, Sylvester J (2004) Advances in brachytherapy. Rev Urol 6:S37\u2013S48","journal-title":"Rev Urol"},{"key":"354_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/B:DRUG.0000006172.65135.3e","volume":"22","author":"C Guerin","year":"2004","unstructured":"Guerin C, Olivi A, Weingart JD et al (2004) Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 22:27\u201337","journal-title":"Invest New Drugs"},{"key":"354_CR10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1072-7515(03)00750-6","volume":"197","author":"LE Harrison","year":"2003","unstructured":"Harrison LE, Koneru B, Baramipour P et al (2003) Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 197:759\u2013764","journal-title":"J Am Coll Surg"},{"key":"354_CR11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1114\/1.1519263","volume":"30","author":"PC Johnson","year":"2002","unstructured":"Johnson PC, Saidel GM (2002) Thermal model for fast simulation during magnetic resonance imaging guidance of radio frequency tumor ablation. Ann Biomed Eng 30:1152\u20131161","journal-title":"Ann Biomed Eng"},{"key":"354_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2006.03.001","volume":"5","author":"ID Kaplan","year":"2006","unstructured":"Kaplan ID, Meskell P, Oldenburg NE et al (2006) Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy 5:147\u2013151","journal-title":"Brachytherapy"},{"key":"354_CR13","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","volume":"11","author":"KM Laginha","year":"2005","unstructured":"Laginha KM, Verwoert S, Charrois GJ et al (2005) Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 11:6944\u20136949","journal-title":"Clin Cancer Res"},{"key":"354_CR14","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1118\/1.2210565","volume":"33","author":"E Lessard","year":"2006","unstructured":"Lessard E, Kwa SL, Pickett B et al (2006) Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist. Med Phys 33:2773\u20132782","journal-title":"Med Phys"},{"key":"354_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cncr.11922","volume":"100","author":"P Menei","year":"2004","unstructured":"Menei P, Jadaud E, Faisant N et al (2004) Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer 100:405\u2013410","journal-title":"Cancer"},{"key":"354_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1227\/01.NEU.0000144982.82068.A2","volume":"56","author":"P Menei","year":"2005","unstructured":"Menei P, Capelle L, Guyotat J et al (2005) Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 56:242\u2013248 discussion 242\u2013248","journal-title":"Neurosurgery"},{"key":"354_CR17","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1208\/aapsj0902027","volume":"9","author":"R Ortiz","year":"2007","unstructured":"Ortiz R, Au JL, Lu Z et al (2007) Biodegradable intraprostatic doxorubicin implants. AAPS J 9:E241\u2013E250","journal-title":"AAPS J"},{"key":"354_CR18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/1097-4636(20010615)55:4<512::AID-JBM1044>3.0.CO;2-N","volume":"55","author":"F Qian","year":"2001","unstructured":"Qian F, Szymanski A, Gao J (2001) Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods. J Biomed Mater Res 55:512\u2013522","journal-title":"J Biomed Mater Res"},{"key":"354_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(03)00237-2","volume":"91","author":"F Qian","year":"2003","unstructured":"Qian F, Stowe N, Liu EH et al (2003) Quantification of in vivo doxorubicin transport from PLGA millirods in thermoablated rat livers. J Control Release 91:157\u2013166","journal-title":"J Control Release"},{"key":"354_CR20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1023\/B:PHAM.0000019290.70358.30","volume":"21","author":"F Qian","year":"2004","unstructured":"Qian F, Stowe N, Saidel GM et al (2004) Comparison of doxorubicin concentration profiles in radiofrequency-ablated rat livers from sustained- and dual-release PLGA millirods. Pharm Res 21:394\u2013399","journal-title":"Pharm Res"},{"key":"354_CR21","first-page":"4584","volume":"48","author":"JA Ridge","year":"1988","unstructured":"Ridge JA, Collin C, Bading JR et al (1988) Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion. Cancer Res 48:4584\u20134587","journal-title":"Cancer Res"},{"key":"354_CR22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/1097-0142(19840315)53:6<1397::AID-CNCR2820530630>3.0.CO;2-E","volume":"53","author":"AJ Swistel","year":"1984","unstructured":"Swistel AJ, Bading JR, Raaf JH (1984) Intraarterial versus intravenous adriamycin in the rabbit Vx-2 tumor system. Cancer 53:1397\u20131404","journal-title":"Cancer"},{"key":"354_CR23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jbm.a.10038","volume":"67A","author":"A Szymanski-Exner","year":"2003","unstructured":"Szymanski-Exner A, Gallacher A, Stowe NT et al (2003) Local carboplatin delivery and tissue distribution in livers after radiofrequency ablation. J Biomed Mat Res 67A:510\u2013516","journal-title":"J Biomed Mat Res"},{"key":"354_CR24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cncr.11919","volume":"100","author":"KK Tanabe","year":"2004","unstructured":"Tanabe KK, Curley SA, Dodd GD et al (2004) Radiofrequency ablation: the experts weigh in. Cancer 100:641\u2013650","journal-title":"Cancer"},{"key":"354_CR25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cncr.20892","volume":"103","author":"R Tateishi","year":"2005","unstructured":"Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201\u20131209","journal-title":"Cancer"},{"key":"354_CR26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/jhep.2001.27219","volume":"34","author":"S Ueno","year":"2001","unstructured":"Ueno S, Tanabe G, Sako K et al (2001) Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 34:529\u2013534","journal-title":"Hepatology"},{"key":"354_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","volume":"93","author":"KB Wallace","year":"2003","unstructured":"Wallace KB (2003) Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 93:105\u2013115","journal-title":"Pharmacol Toxicol"},{"key":"354_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jbm.a.30914","volume":"81","author":"BD Weinberg","year":"2007","unstructured":"Weinberg BD, Ai H, Blanco E et al (2007) Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res A 81:161\u2013170","journal-title":"J Biomed Mater Res A"},{"key":"354_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jbm.a.30926","volume":"81","author":"BD Weinberg","year":"2007","unstructured":"Weinberg BD, Blanco E, Lempka SF et al (2007) Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. J Biomed Mater Res A 81:205\u2013213","journal-title":"J Biomed Mater Res A"},{"key":"354_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2007.08.023","volume":"124","author":"BD Weinberg","year":"2007","unstructured":"Weinberg BD, Patel RB, Exner AA et al (2007) Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. J Control Release 124:11\u201319","journal-title":"J Control Release"},{"key":"354_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2006.03.004","volume":"5","author":"Y Yamada","year":"2006","unstructured":"Yamada Y, Bhatia S, Zaider M et al (2006) Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 5:157\u2013164","journal-title":"Brachytherapy"}],"container-title":["Medical & Biological Engineering & Computing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-008-0354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11517-008-0354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-008-0354-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T16:06:56Z","timestamp":1559405216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11517-008-0354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,4]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s11517-008-0354-7","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"value":"0140-0118","type":"print"},{"value":"1741-0444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,4]]}}}